https://www.biospace.com/can-fite-reports-on-progress-with-its-namodenoson-nash-program
Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE:CFBI), a biotechnology company advancing a pipeline of proprietary small molecule drugs that address...
fitereportsprogressnamodenosonnash